These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7833589)

  • 1. The role of interleukin-6 in certain age-related diseases.
    Ershler WB; Sun WH; Binkley N
    Drugs Aging; 1994 Nov; 5(5):358-65. PubMed ID: 7833589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6: a cytokine for gerontologists.
    Ershler WB
    J Am Geriatr Soc; 1993 Feb; 41(2):176-81. PubMed ID: 8426042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.
    Ershler WB; Keller ET
    Annu Rev Med; 2000; 51():245-70. PubMed ID: 10774463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction.
    Ershler WB; Sun WH; Binkley N; Gravenstein S; Volk MJ; Kamoske G; Klopp RG; Roecker EB; Daynes RA; Weindruch R
    Lymphokine Cytokine Res; 1993 Aug; 12(4):225-30. PubMed ID: 8218595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6: structure-function relationships.
    Simpson RJ; Hammacher A; Smith DK; Matthews JM; Ward LD
    Protein Sci; 1997 May; 6(5):929-55. PubMed ID: 9144766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
    Hirano T; Matsuda T; Nakajima K
    Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis.
    Edwards CJ; Williams E
    Osteoporos Int; 2010 Aug; 21(8):1287-93. PubMed ID: 20229200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 and the skin.
    Paquet P; Piérard GE
    Int Arch Allergy Immunol; 1996 Apr; 109(4):308-17. PubMed ID: 8634514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes.
    Omoigui S
    Med Hypotheses; 2005; 65(3):559-69. PubMed ID: 15935563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut, inflammation and osteoporosis: basic and clinical concepts.
    Tilg H; Moschen AR; Kaser A; Pines A; Dotan I
    Gut; 2008 May; 57(5):684-94. PubMed ID: 18408105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related increase in IL-17 activates pro-inflammatory signaling in prostate cells.
    De Angulo A; Faris R; Daniel B; Jolly C; deGraffenried L
    Prostate; 2015 Apr; 75(5):449-62. PubMed ID: 25560177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IL-23R, a novel susceptibility gene for inflammatory bowel disease].
    Peyrin-Biroulet L; Parmentier-Decrucq E; Branche J; Desreumaux P
    Med Sci (Paris); 2007 Mar; 23(3):250-2. PubMed ID: 17349281
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiological and pathological roles of interleukin-6 in the central nervous system.
    Gruol DL; Nelson TE
    Mol Neurobiol; 1997 Dec; 15(3):307-39. PubMed ID: 9457704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures.
    Franchimont N; Durant D; Canalis E
    Endocrinology; 1997 Aug; 138(8):3380-6. PubMed ID: 9231791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
    Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
    Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage.
    Schneider CP; Schwacha MG; Chaudry IH
    Biochim Biophys Acta; 2004 May; 1689(1):22-32. PubMed ID: 15158910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokine binding proteins: a model of interleukin 6].
    Brailly H; Montero-Julian FA
    Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
    Lasfar A; Wietzerbin J; Billard C
    Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.